Abstract
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality throughout the world. Although the incidence of AMI is higher in men than women, it is responsible for more than 250,000 annual deaths among women within the United States alone. Coronary thrombolysis is the treatment of choice for AMI and reduces mortality rates in both men and women. However, the absolute benefit may be less in women and, in addition, may not be maintained beyond the early postinfarction period. Bleeding complications, including intracranial hemorrhage, may be more common in women, particularly those more than 65 years of age. The author reviews the topic of coronary thrombolysis in women.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
